These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 18834363

  • 21. [Evaluation of transcatheter arterial chemoembolization in the prevention of postoperative recurrence in 1630 patients with hepatocellular carcinoma].
    Cheng HY, Xu W, Xu AM, Chen D, Yang YF, Jia YC.
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):626-8. PubMed ID: 16438876
    [Abstract] [Full Text] [Related]

  • 22. [Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma].
    Kim MH, Choi MS, Choi YS, Kim DY, Lee JM, Paik SW, Lee JH, Koh KC, Yoo BC, Choi D, Rhee JC.
    Korean J Hepatol; 2006 Mar; 12(1):55-64. PubMed ID: 16565606
    [Abstract] [Full Text] [Related]

  • 23. Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trial.
    Tian G, Liu J, Zhou JS, Chen W.
    Anticancer Drugs; 2009 Jun; 20(5):389-95. PubMed ID: 19287305
    [Abstract] [Full Text] [Related]

  • 24. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M, Lu C, Cheng J, Zhang J, Cao C, Xu J, Xu J, Pan H, Zhong B, Tucker S, Wang D.
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [Abstract] [Full Text] [Related]

  • 25. Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization.
    Shen H, Agarwal D, Qi R, Chalasani N, Liangpunsakul S, Lumeng L, Yoo H, Kwo P.
    Aliment Pharmacol Ther; 2007 Aug 01; 26(3):393-400. PubMed ID: 17635374
    [Abstract] [Full Text] [Related]

  • 26. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus.
    Peng BG, He Q, Li JP, Zhou F.
    Am J Surg; 2009 Sep 01; 198(3):313-8. PubMed ID: 19285298
    [Abstract] [Full Text] [Related]

  • 27. Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization.
    Lu W, Li YH, He XF, Zhao JB, Chen Y, Mei QL.
    Cardiovasc Intervent Radiol; 2008 Sep 01; 31(6):1133-40. PubMed ID: 18584240
    [Abstract] [Full Text] [Related]

  • 28. Caffeine clearance in patients with hepatocellular carcinoma after transcatheter oily chemoembolization treatment.
    Thong-Ngam D, Thumvijit L, Tangkijvanich P, Janchai A, Mahachai V, Wittayalertpanya S.
    J Med Assoc Thai; 2002 Dec 01; 85(12):1280-7. PubMed ID: 12678165
    [Abstract] [Full Text] [Related]

  • 29. Influence of preoperative transcatheter arterial chemoembolization on liver resection in patients with resectable hepatocellular carcinoma.
    Luo YQ, Wang Y, Chen H, Wu MC.
    Hepatobiliary Pancreat Dis Int; 2002 Nov 01; 1(4):523-6. PubMed ID: 14607679
    [Abstract] [Full Text] [Related]

  • 30. [A successful case of hepatocellular carcinoma with portal venous tumor thrombus (Vp2) treated by transcatheter arterial chemoembolization].
    Noda T, Nagano H, Miyamoto A, Wada H, Damdinsuren B, Marubashi S, Takeda Y, Umeshita K, Dono K, Ohsuga K, Kim T, Tomoda K, Nakamura H, Monden M.
    Gan To Kagaku Ryoho; 2006 Nov 01; 33(12):1931-4. PubMed ID: 17212150
    [Abstract] [Full Text] [Related]

  • 31. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
    Eguchi S, Matsumoto S, Hamasaki K, Takatsuki M, Hidaka M, Tajima Y, Sakamoto I, Kanematsu T.
    J Hepatobiliary Pancreat Surg; 2008 Nov 01; 15(6):627-33. PubMed ID: 18987934
    [Abstract] [Full Text] [Related]

  • 32. [Relation between vascular endothelial growth factor and reoccurence-metastasis after transcatheter arterial chemoembolization in hepatocellar carcinoma].
    Xiong ZP, Yang SR, Xiao EH, Zhou SK, Zhang ZS, Liang ZY.
    Zhonghua Zhong Liu Za Zhi; 2003 Nov 01; 25(6):562-5. PubMed ID: 14690562
    [Abstract] [Full Text] [Related]

  • 33. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
    Lee KT, Lu YW, Wang SN, Chen HY, Chuang SC, Chang WT, Shi HY, Ker CG, Chiu HC.
    J Surg Oncol; 2009 May 01; 99(6):343-50. PubMed ID: 19226530
    [Abstract] [Full Text] [Related]

  • 34. [Effectiveness of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Gao HJ, Liang HH, Chen MS, Peng ZW, Zhang YJ, Li P, Pang XH, Zhang YQ, Li JQ.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 23; 88(36):2529-32. PubMed ID: 19080642
    [Abstract] [Full Text] [Related]

  • 35. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma.
    Lu W, Li YH, Yu ZJ, He XF, Chen Y, Zhao JB, Zhu ZY.
    Hepatogastroenterology; 2007 Sep 23; 54(77):1499-502. PubMed ID: 17708284
    [Abstract] [Full Text] [Related]

  • 36. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma.
    Takeshita S, Ichikawa T, Nakao K, Miyaaki H, Shibata H, Matsuzaki T, Muraoka T, Honda T, Otani M, Akiyama M, Miuma S, Ozawa E, Fujimito M, Eguchi K.
    Nutr Res; 2009 Feb 23; 29(2):89-93. PubMed ID: 19285598
    [Abstract] [Full Text] [Related]

  • 37. Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma.
    Graf H, Jüngst C, Straub G, Dogan S, Hoffmann RT, Jakobs T, Reiser M, Waggershauser T, Helmberger T, Walter A, Walli A, Seidel D, Goke B, Jüngst D.
    Digestion; 2008 Feb 23; 78(1):34-8. PubMed ID: 18797167
    [Abstract] [Full Text] [Related]

  • 38. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
    Yu Y, Lang Q, Chen Z, Li B, Yu C, Zhu D, Zhai X, Ling C.
    Cancer; 2009 Nov 15; 115(22):5132-8. PubMed ID: 19672999
    [Abstract] [Full Text] [Related]

  • 39. Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver.
    Poggi G, Pozzi E, Riccardi A, Tonini S, Montagna B, Quaretti P, Tagliaferri B, Sottotetti F, Baiardi P, Pagella C, Minoia C, Bernardo G.
    Anticancer Res; 2010 Dec 15; 30(12):5159-64. PubMed ID: 21187505
    [Abstract] [Full Text] [Related]

  • 40. Risk factors for death in 224 cases of hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi H, Yamamoto Y, Ichikawa S, Hasebe A, Yano M, Miyamoto Y, Ninomiya T, Ootani H, Takamura K, Kawasaki H, Otomi Y, Kogame M, Sogabe I, Ishimaru Y, Kashihara K, Miyagawa M, Hirooka M, Hiasa Y, Matsuura B, Michitaka K, Onji M.
    Hepatogastroenterology; 2009 Dec 15; 56(89):213-7. PubMed ID: 19453060
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.